Daxor Corporation ( DXR) - Key Metrics
DXR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.66 | -$0.50 | -$0.50 |
| 2025Q4 | $0.03 | $1.89 | -$0.06 | -$0.06 |
| 2025Q2 | $0 | -$0.07 | $0.09 | $0.09 |
| 2024Q4 | $0.14 | $0.44 | -$0.10 | -$0.10 |
| 2024Q2 | $0.01 | -$0.34 | -$0.19 | -$0.19 |
DXR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.90 |
| 2025Q4 | 0% | 1.95 |
| 2025Q2 | 0% | -32.99 |
| 2024Q4 | 0% | 4.37 |
| 2024Q2 | 0% | -6.62 |
DXR
Price: $11.40
52 week price:
Earnings Per Share: 1.69 USD
P/E Ratio: 6.08
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 5100
Market Capitalization: 60.0 million